Allstate Corporation’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.2M | Buy |
39,150
+10,428
| +36% | +$5.66M | 0.21% | 65 |
|
|
2025
Q4 | $16.6M | Buy |
28,722
+14,969
| +109% | +$8.46M | 0.23% | 55 |
|
|
2025
Q3 | $6.67M | Buy |
+13,753
| New | +$6.4M | 0.15% | 70 |
|
|
2025
Q2 | – | Sell |
-13,911
| Closed | -$6.92M | – | 523 |
|
|
2025
Q1 | $6.92M | Buy |
13,911
+2,540
| +22% | +$1.38M | 0.2% | 61 |
|
|
2024
Q4 | $5.92M | Buy |
11,371
+11,033
| +3,264% | +$6.07M | 0.17% | 57 |
|
|
2024
Q3 | $209K | Sell |
338
-922
| -73% | -$546K | 0.02% | 103 |
|
|
2024
Q2 | $697K | Sell |
1,260
-8
| -0.6% | -$4.58K | 0.06% | 91 |
|
|
2024
Q1 | $737K | Sell |
1,268
-39
| -3% | -$21.9K | 0.05% | 88 |
|
|
2023
Q4 | $694K | Sell |
1,307
-192
| -13% | -$92.9K | 0.05% | 86 |
|
|
2023
Q3 | $759K | Hold |
1,499
| – | – | 0.04% | 80 |
|
|
2023
Q2 | $782K | Sell |
1,499
-1
| -0.1% | -$540 | 0.05% | 84 |
|
|
2023
Q1 | $865K | Sell |
1,500
-14,660
| -91% | -$8.26M | 0.06% | 75 |
|
|
2022
Q4 | $8.9M | Buy |
16,160
+199
| +1% | +$105K | 0.27% | 53 |
|
|
2022
Q3 | $8.1M | Buy |
15,961
+471
| +3% | +$264K | 0.23% | 57 |
|
|
2022
Q2 | $8.41M | Buy |
15,490
+5,211
| +51% | +$2.87M | 0.26% | 48 |
|
|
2022
Q1 | $6.07M | Sell |
10,279
-22,112
| -68% | -$12.7M | 0.16% | 85 |
|
|
2021
Q4 | $21.6M | Buy |
32,391
+22,471
| +227% | +$14M | 0.41% | 35 |
|
|
2021
Q3 | $5.67M | Sell |
9,920
-688
| -6% | -$378K | 0.23% | 36 |
|
|
2021
Q2 | $5.35M | Sell |
10,608
-1,382
| -12% | -$652K | 0.18% | 40 |
|
|
2021
Q1 | $5.47M | Buy |
11,990
+1,498
| +14% | +$715K | 0.17% | 46 |
|
|
2020
Q4 | $4.89M | Sell |
10,492
-293
| -3% | -$137K | 0.15% | 47 |
|
|
2020
Q3 | $4.76M | Sell |
10,785
-1,760
| -14% | -$727K | 0.15% | 43 |
|
|
2020
Q2 | $4.55M | Sell |
12,545
-1,298
| -9% | -$435K | 0.16% | 53 |
|
|
2020
Q1 | $3.93M | Sell |
13,843
-26,777
| -66% | -$8.44M | 0.15% | 51 |
|
|
2019
Q4 | $13.2M | Sell |
40,620
-4
| -0% | -$1.21K | 0.24% | 47 |
|
|
2019
Q3 | $11.8M | Buy |
40,624
+14
| +0% | +$4.01K | 0.2% | 49 |
|
|
2019
Q2 | $11.9M | Buy |
40,610
+6
| +0% | +$1.65K | 0.21% | 50 |
|
|
2019
Q1 | $11.1M | Sell |
40,604
-132
| -0.3% | -$32.9K | 0.3% | 49 |
|
|
2018
Q4 | $9.12M | Buy |
+40,736
| New | +$9.56M | 0.3% | 51 |
|
|
2017
Q3 | – | Sell |
-19,902
| Closed | -$3.47M | – | 231 |
|
|
2017
Q2 | $3.47M | Buy |
19,902
+3,446
| +21% | +$579K | 0.18% | 42 |
|
|
2017
Q1 | $2.53M | Buy |
16,456
+2,681
| +19% | +$410K | 0.15% | 97 |
|
|
2016
Q4 | $1.94M | Sell |
13,775
-17,374
| -56% | -$2.56M | 0.12% | 189 |
|
|
2016
Q3 | $4.96M | Buy |
31,149
+556
| +2% | +$85.7K | 0.35% | 81 |
|
|
2016
Q2 | $4.52M | Sell |
30,593
-23,831
| -44% | -$3.52M | 0.3% | 85 |
|
|
2016
Q1 | $7.71M | Sell |
54,424
-18,904
| -26% | -$2.53M | 0.66% | 54 |
|
|
2015
Q4 | $10.4M | Buy |
73,328
+43,222
| +144% | +$5.76M | 0.99% | 26 |
|
|
2015
Q3 | $3.68M | Buy |
30,106
+12,046
| +67% | +$1.57M | 0.38% | 63 |
|
|
2015
Q2 | $2.34M | Buy |
18,060
+1,952
| +12% | +$254K | 0.21% | 108 |
|
|
2015
Q1 | $2.16M | Buy |
16,108
+5,572
| +53% | +$718K | 0.18% | 159 |
|
|
2014
Q4 | $1.32M | Sell |
10,536
-3,081
| -23% | -$375K | 0.1% | 194 |
|
|
2014
Q3 | $1.66M | Buy |
13,617
+2,833
| +26% | +$344K | 0.08% | 225 |
|
|
2014
Q2 | $1.27M | Buy |
+10,784
| New | +$1.27M | 0.03% | 213 |
|
Other funds holding TMO
VCM
Allstate Corporation's TMO Position: Q1 2026 in Review
Allstate Corporation increased its Thermo Fisher Scientific (TMO) stake by 36% in Q1 2026, buying an estimated $5.66M and bringing the position to 39,150 shares worth $19.2M. The position accounts for 0.21% of the portfolio, ranked #65.
Allstate Corporation first reported a position in TMO in Q2 2014 and has held it in 42 quarters since. The position peaked at $21.6M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Allstate Corporation held 39,150 shares of Thermo Fisher Scientific worth $19.2M as of Q1 2026.
- Allstate Corporation bought 10,428 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.66M.
- Thermo Fisher Scientific made up 0.21% of Allstate Corporation's portfolio in Q1 2026, its #65 holding.
- Allstate Corporation first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 42 quarters since.
- Allstate Corporation's Thermo Fisher Scientific position peaked at $21.6M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.